MLN2201
Product Specifications
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Bioactivity
MLN2201 is a humanized monoclonal antibody inhibitor that targets Integrinβ2. It can inhibit reperfusion injury following a stroke and is applicable for researching inflammatory conditions such as ischemic stroke.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-CL-H0348-01 24 Tests
Human ICAM4 -Intercellular Adhesion Molecule 4- CLIA Kit
Sign In for Pricing
View Details E-CL-H0348-02 48 Tests
Human ICAM4 -Intercellular Adhesion Molecule 4- CLIA Kit
Sign In for Pricing
View Details